James L. Cox - Jan 31, 2023 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ James L. Cox
Stock symbol
LUCD
Transactions as of
Jan 31, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 07:38 PM
Previous filing
Feb 2, 2023
Next filing
Feb 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUCD Employee stock option (right to buy) Award $0 +175K $0.00 175K Jan 31, 2023 Common stock 175K $1.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023.